Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal tissue, composed of neural and vascular elements, is the target of laser photocoagulation. This procedure aims to treat various retinal diseases by creating controlled thermal burns that induce scarring, seal leaking blood vessels, destroy abnormal new vessel growth, and stabilize the retina. The goal is to prevent further vision loss, although some degree of collateral damage to healthy tissue is possible.
Laser photocoagulation induces thermal damage to retinal tissue, leading to coagulation, scarring, and destruction of abnormal vessels or sealing of retinal breaks.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal Tissue.